• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖患者甲状旁腺功能正常时,因体内存在抗鼠抗体导致的人甲状旁腺激素免疫检测干扰。

PTH Immunoassay Interference Due to Human Anti-Mouse Antibodies in a Subject With Obesity With Normal Parathyroid Function.

机构信息

Division of Endocrinology, Diabetology and Clinical Nutrition, Department of Medicine 1, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.

出版信息

J Clin Endocrinol Metab. 2019 Dec 1;104(12):5840-5842. doi: 10.1210/jc.2019-01321.

DOI:10.1210/jc.2019-01321
PMID:31411693
Abstract

CONTEXT

Immunoassay interference has been most often found with prolactin measurement. However, only few data exist on immunoassay interference for other hormones.

CASE DESCRIPTION

A 36-year-old woman with obesity (body mass index, 31 kg/m2) had regularly attended our endocrine unit for type 2 diabetes therapy. When she was included as a control subject in a study for obesity management, detailed laboratory testing was performed, including PTH. In the absence of clinical symptoms, she presented with normal calcium, phosphate, and vitamin D levels. However, the PTH levels were >5000 ng/L. These results were obtained using the Roche Elecsys electrochemiluminescence assay. Repeated measurements with this assay (mouse antibody) led to the same findings. However, using an Euroimmun assay (goat antibody), the exact PTH values were measured at 18.0 ng/L. After pretreatment with a heterophilic antibody blocking reagent, the results of the Roche assay had decreased to a normal level. This phenomenon was explained by the detection of human anti-mouse antibodies in the proband's serum.

CONCLUSIONS

In cases of prolactin immunoassay interference, endogenous antibodies will bind to the hormone in vivo, resulting in complexes of a high molecular weight that are less efficiently cleared by the kidneys and, thus, accumulate in the blood. In contrast, the PTH values >5000 ng/L detected in our subject most likely had resulted from the specific interference of the human anti-mouse antibodies present in the proband's serum with the assay antibody, resulting in artificial stimulation of the Roche assay detection system ex vivo.

摘要

背景

免疫测定干扰最常发生在催乳素测量中。然而,关于其他激素的免疫测定干扰,仅有少数数据存在。

病例描述

一位 36 岁的肥胖女性(体重指数 31kg/m2)定期到我们的内分泌科接受 2 型糖尿病治疗。当她被纳入肥胖管理研究的对照组时,进行了详细的实验室检查,包括甲状旁腺激素(PTH)。尽管她没有出现临床症状,但钙、磷和维生素 D 水平正常。然而,PTH 水平>5000ng/L。这些结果是使用罗氏 Elecsys 电化学发光分析法获得的。使用该检测方法(鼠抗体)进行了重复测量,结果相同。然而,使用 Euroimmun 检测方法(羊抗体),准确的 PTH 值测量值为 18.0ng/L。在用异嗜性抗体阻断试剂预处理后,罗氏检测方法的结果降低至正常水平。这种现象是由于在该患者的血清中检测到人类抗鼠抗体而导致的。

结论

在催乳素免疫测定干扰的情况下,内源性抗体将在体内与激素结合,形成高分子量的复合物,这些复合物的清除效率较低,因此在血液中积累。相比之下,我们的患者检测到的 PTH 值>5000ng/L 很可能是由于患者血清中存在的人类抗鼠抗体特异性干扰了检测抗体,导致罗氏检测系统在体外被人为刺激。

相似文献

1
PTH Immunoassay Interference Due to Human Anti-Mouse Antibodies in a Subject With Obesity With Normal Parathyroid Function.肥胖患者甲状旁腺功能正常时,因体内存在抗鼠抗体导致的人甲状旁腺激素免疫检测干扰。
J Clin Endocrinol Metab. 2019 Dec 1;104(12):5840-5842. doi: 10.1210/jc.2019-01321.
2
Falsely elevated parathyroid hormone in a patient with osteoporosis: a case report and review.骨质疏松症患者甲状旁腺激素假性升高:病例报告及文献复习。
Osteoporos Int. 2024 Apr;35(4):737-740. doi: 10.1007/s00198-023-07006-z. Epub 2023 Dec 28.
3
Asymptomatic elevation of parathyroid hormone levels by antibodies against reagent alkaline phosphatase.试剂碱性磷酸酶抗体导致甲状旁腺激素水平无症状性升高。
Clin Chim Acta. 2024 Mar 15;556:117821. doi: 10.1016/j.cca.2024.117821. Epub 2024 Feb 9.
4
Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.在Elecsys 2010和1010系统上对一种用于完整甲状旁腺激素测量的新型免疫测定法进行多中心评估。
Clin Lab. 2002;48(3-4):131-41.
5
A Case With Immunoassay Interferences in the Measurement of Multiple Hormones.一例多种激素检测中免疫测定干扰的病例
J Clin Endocrinol Metab. 2015 Jun;100(6):2147-53. doi: 10.1210/jc.2014-4023. Epub 2015 Apr 21.
6
Human anti-mouse antibodies interferences in Elecsys PTH assay after OKT3 treatment.OKT3治疗后人体抗小鼠抗体对电化学发光免疫分析法检测甲状旁腺激素的干扰。
Transplantation. 2009 Feb 15;87(3):451-2. doi: 10.1097/TP.0b013e31819575a1.
7
Asymptomatic elevated parathyroid hormone level due to immunoassay interference.因免疫测定干扰导致无症状甲状旁腺激素水平升高。
Osteoporos Int. 2021 Oct;32(10):2111-2114. doi: 10.1007/s00198-021-05950-2. Epub 2021 Apr 24.
8
Interference of circulating endogenous antibodies on the Dimension® DGNA digoxin immunoassay: elimination with a heterophilic blocking reagent.循环内源性抗体对 Dimension® DGNA 地高辛免疫测定的干扰:用异嗜性封闭试剂消除。
Clin Biochem. 2010 Dec;43(18):1475-7. doi: 10.1016/j.clinbiochem.2010.09.018. Epub 2010 Sep 26.
9
Heterophilic antibody interference in a tryptase immunoassay.类嗜异性抗体对类胰蛋白酶免疫测定的干扰
Clin Biochem. 2008 Mar;41(4-5):331-4. doi: 10.1016/j.clinbiochem.2007.11.003. Epub 2007 Nov 17.
10
Heterophilic antibody interference in immunometric assays.免疫分析中的异嗜性抗体干扰。
Best Pract Res Clin Endocrinol Metab. 2013 Oct;27(5):647-61. doi: 10.1016/j.beem.2013.05.011. Epub 2013 Jun 20.

引用本文的文献

1
PTH immunoassay interference: differential diagnosis with normocalcemic primary hyperparathyroidism?PTH 免疫测定干扰:伴有血钙正常的原发性甲状旁腺功能亢进症的鉴别诊断?
Arch Endocrinol Metab. 2024 Nov 6;68:e230315. doi: 10.20945/2359-4292-2023-0315. eCollection 2024.
2
Falsely elevated parathyroid hormone in a patient with osteoporosis: a case report and review.骨质疏松症患者甲状旁腺激素假性升高:病例报告及文献复习。
Osteoporos Int. 2024 Apr;35(4):737-740. doi: 10.1007/s00198-023-07006-z. Epub 2023 Dec 28.
3
Insulin Immunoassay Interference Due to Human Antimouse Antibodies in a Patient With Ketotic Hypoglycemia.
酮症性低血糖患者中人类抗鼠抗体导致的胰岛素免疫测定干扰
JCEM Case Rep. 2023 Mar 23;1(2):luad029. doi: 10.1210/jcemcr/luad029. eCollection 2023 Mar.
4
Macro-PTH, a rare cause of unexplained elevated serum PTH levels.大分子甲状旁腺激素,是血清甲状旁腺激素水平不明原因升高的罕见原因。
J Endocrinol Invest. 2023 May;46(5):1039-1040. doi: 10.1007/s40618-023-02049-9. Epub 2023 Mar 2.
5
Hormone Immunoassay Interference: A 2021 Update.激素免疫测定干扰:2021 更新版。
Ann Lab Med. 2022 Jan 1;42(1):3-23. doi: 10.3343/alm.2022.42.1.3.